- Report
- June 2025
- 183 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- April 2025
- 185 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- February 2025
- 182 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- January 2025
- 180 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1114EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1114EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 50 Pages
Global
From €1337EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1337EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1337EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1114EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1337EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1114EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1114EUR$1,250USD£966GBP
- Report
- May 2025
- 231 Pages
Global
From €2228EUR$2,500USD£1,933GBP
- Report
- June 2025
- 200 Pages
Global
From €2485EUR$2,789USD£2,156GBP
- Report
- June 2025
- 150 Pages
Global
From €2405EUR$2,699USD£2,086GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2485EUR$2,789USD£2,156GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2485EUR$2,789USD£2,156GBP
- Report
- March 2025
- 91 Pages
Global
From €3500EUR$4,207USD£3,143GBP
- Report
- January 2025
- 250 Pages
Global
From €4455EUR$4,999USD£3,864GBP

The Antifungal Drug market is a subset of the larger Infectious Diseases Drugs market. Antifungal drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common antifungal drugs include azoles, polyenes, and echinocandins. Azoles are the most commonly prescribed antifungal drugs, and are used to treat a wide range of fungal infections. Polyenes are used to treat more serious fungal infections, while echinocandins are used to treat severe fungal infections.
The Antifungal Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Other companies in the market include Bayer, Sanofi, Allergan, and Johnson & Johnson. Show Less Read more